Lördag 10 Maj | 01:32:32 Europe / Stockholm

Kalender

Est. tid*
2025-11-11 07:30 Kvartalsrapport 2025-Q3
2025-08-19 07:30 Kvartalsrapport 2025-Q2
2025-05-28 N/A X-dag ordinarie utdelning NORDH 0.00 NOK
2025-05-27 N/A Årsstämma
2025-05-13 07:30 Kvartalsrapport 2025-Q1
2025-03-04 - Bokslutskommuniké 2024
2024-11-12 - Kvartalsrapport 2024-Q3
2024-08-20 - Kvartalsrapport 2024-Q2
2024-05-30 - Årsstämma
2024-05-24 - X-dag ordinarie utdelning NORDH 0.00 NOK
2024-05-14 - Kvartalsrapport 2024-Q1
2024-03-05 - Bokslutskommuniké 2023
2023-08-22 - Kvartalsrapport 2023-Q2
2023-05-08 - X-dag ordinarie utdelning NORDH 0.00 NOK
2023-04-24 - Årsstämma
2023-03-07 - Bokslutskommuniké 2022
2022-11-25 - Kvartalsrapport 2022-Q3
2022-08-16 - Kvartalsrapport 2022-Q2
2022-06-02 - Årsstämma
2022-05-20 - Kvartalsrapport 2022-Q1
2022-05-09 - X-dag ordinarie utdelning NORDH 0.00 NOK
2022-03-08 - Bokslutskommuniké 2021
2022-02-17 - Extra Bolagsstämma 2022
2021-11-30 - Kvartalsrapport 2021-Q3

Beskrivning

LandNorge
ListaEuronext Growth Oslo
SektorInformationsteknik
IndustriProgramvara
NordHealth är verksamma inom teknikbranschen. Bolaget är specialiserade inom utveckling av mjukvara för digital hälsa. Programvaran är egenutvecklad och används huvudsakligen inom hälsovårdssektorn. Kunderna består av företagskunder verksamma i olika sektorer som sjukhus, kliniker, veterinärer. Utöver huvudverksamheten erbjuds även diverse mervärdestjänster. Störst verksamhet återfinns inom Norden.
2023-06-05 09:30:15
Nordhealth AS (the "Company") has decided to initiate a buyback for a maximum
consideration of NOK 4 million and for up to 400,000 of its own shares in
accordance with the authorization granted to the board of directors by the
Company's annual general meeting held on 24 April 2023.

The share buyback program will be for a maximum consideration of NOK 4 million,
and for a maximum of 400,000 shares. The repurchases will be conducted in the
period from 5 June 2023 until and including 31 December 2023, or until the
maximum number of shares has been repurchased. Buyback transactions will be
executed according to the market price on the Oslo Stock Exchange, and the
maximum price to be paid per share under the program is NOK 30.

Any shares acquired as part of the buyback program will be used as consideration
in future acquisitions by the company, as part the employee share program, or
absent of this, be cancelled. Any shares purchased will be held in treasury
until used for the above purposes.

The maximum number of shares purchased per day will be 25% of the average daily
turnover in the 20 trading days preceding the date of purchase. This limit is in
accordance with Market Abuse Regulation (MAR) requirements as described in
Article 3 of the EU Commission delegated regulation 2016/1052, and as
implemented in Norway under the Securities Trading Act.

For further information, please contact:

Charles Macbain, CEO

charles.macbain@nordhealth.com

Mari Orttenvuori, CFO

mari.orttenvuori@nordhealth.com

About Nordhealth

Nordhealth is a publicly listed, fast-growing cloud-based healthcare SaaS
company on a mission to redefine digital healthcare. We build software that
empower veterinary and therapy professionals to provide the best possible care
experiences to their patients. Our products serve more than 50,000 veterinary
and therapy professionals across 13,000 clinics and hospitals located in over 30
countries.

Headquartered in Helsinki, Finland, Nordhealth has a solid footprint in the
Nordic region and a growing presence internationally, with more than 380
employees working either remotely or from offices (collaboration hubs). Visit
the company's website at nordhealth.com (http://www.nordhealth.com).